SEC Comment Letter for HCW Biologics Inc. (HCWB) (CIK 0001828673) (HCWB) — Jun 12, 2026
HCW Biologics Inc. (HCWB) (CIK 0001828673)
Date: June 12, 2026 · CIK: 0001828673 · Accession: 0000000000-26-005926
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296577
Letter
Re: HCW Biologics Inc. Registration Statement on Form S-1 Filed June 8, 2026 File No. 333-296577 Dear Hing Wong: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions.
June 12, 2026
Hing Wong Chief Executive Officer HCW Biologics Inc. 2929 N Commerce Parkway Miramar, FL 33025
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeny Zarmon
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 12, 2026 Hing Wong Chief Executive Officer HCW Biologics Inc. 2929 N Commerce Parkway Miramar, FL 33025 Re: HCW Biologics Inc. Registration Statement on Form S-1 Filed June 8, 2026 File No. 333-296577 Dear Hing Wong: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeny Zarmon </TEXT> </DOCUMENT>